Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Heemann

Showing results (11-20 of 283) with videos related to

Pageof 29
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2014
Blocking innate immunity to slow the progression of chronic kidney diseaseChristoph Schmaderer, Uwe Heemann
Clinical Transplantation|December 4, 2012
The role of belataceptin transplantation: results and implications of clinical trials in the context of other new biological immunosuppressant agentsUwe Heemann, Ondrej Viklicky
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
CMV prophylaxis: what is valid in 2002?Uwe Heemann, Rene R Wenzel
Medizinische Klinik (Munich, Germany : 1983)|March 21, 2003
[Nephrology--Part 2. Strategies in the immunosuppression after kidney transplantation]Heide Sperschneider, Uwe Heemann, Günter Stein
Journal of Nephrology|September 4, 2016
Renal dysfunction following bone marrow transplantationStephan Kemmner, Mareike Verbeek, Uwe Heemann
MMW Fortschritte Der Medizin|August 20, 2013
[Update nephrology 2013]Christoph Schmaderer, Uwe Heemann, Philipp Moog
Diabetes Care|January 21, 2010
Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose toleranceStefan Pscherer, Uwe Heemann, Helga Frank
Journal of Inflammation (London, England)|June 1, 2010
Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantationJens Lutz, Klaus Thürmel, Uwe Heemann
Hypertension (Dallas, Tex. : 1979)|May 29, 2014
Microcirculatory marker for the prediction of renal end points: a prospective cohort study in patients with chronic kidney disease stage 2 to 4Marcus Baumann, Klaus Burkhardt, Uwe Heemann
Deutsche Medizinische Wochenschrift (1946)|October 8, 2015
[The hepatorenal syndrome]Uwe Heemann, Hermann S Füeßl, Lutz Renders
Pageof 29

Showing results (11-20 of 283) with videos related to

Sort By:
Pageof 29
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2014
Blocking innate immunity to slow the progression of chronic kidney diseaseChristoph Schmaderer, Uwe Heemann
Clinical Transplantation|December 4, 2012
The role of belataceptin transplantation: results and implications of clinical trials in the context of other new biological immunosuppressant agentsUwe Heemann, Ondrej Viklicky
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
CMV prophylaxis: what is valid in 2002?Uwe Heemann, Rene R Wenzel
Medizinische Klinik (Munich, Germany : 1983)|March 21, 2003
[Nephrology--Part 2. Strategies in the immunosuppression after kidney transplantation]Heide Sperschneider, Uwe Heemann, Günter Stein
Journal of Nephrology|September 4, 2016
Renal dysfunction following bone marrow transplantationStephan Kemmner, Mareike Verbeek, Uwe Heemann
MMW Fortschritte Der Medizin|August 20, 2013
[Update nephrology 2013]Christoph Schmaderer, Uwe Heemann, Philipp Moog
Diabetes Care|January 21, 2010
Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose toleranceStefan Pscherer, Uwe Heemann, Helga Frank
Journal of Inflammation (London, England)|June 1, 2010
Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantationJens Lutz, Klaus Thürmel, Uwe Heemann
Hypertension (Dallas, Tex. : 1979)|May 29, 2014
Microcirculatory marker for the prediction of renal end points: a prospective cohort study in patients with chronic kidney disease stage 2 to 4Marcus Baumann, Klaus Burkhardt, Uwe Heemann
Deutsche Medizinische Wochenschrift (1946)|October 8, 2015
[The hepatorenal syndrome]Uwe Heemann, Hermann S Füeßl, Lutz Renders
Pageof 29